The Value Proposition of Molecular Medicine

The value proposition of molecular medicine.

The value of war for medicine: questions and considerations concerning an often endorsed proposition.

This paper examines the relationship, often claimed as beneficial, between war and advances in medicine and surgery. Some of the conflicting opinions that have been expressed are discussed. Military medicine in general is conservative and non-innovative. Some medical advances have indeed originated in war, but many other efforts were failures and are forgotten. The application of others is limi...

The quality-value proposition in health care.

Powerful forces are converging in US health care to finally cause recognition of the inherently logical relationship between quality and money. The forces, or marketplace "drivers," which are converging to compel recognition of the relationship between cost and quality are: (1) the increasing costs of care; (2) the recurrence of another medical malpractice crisis; and (3) the recognition inside...

The value proposition in percutaneous coronary intervention.

New therapies are incorporated into clinical practice for a variety of reasons. Usually, they are more efficacious than what is currently used for a specific disease state. Sometimes, they are just as efficacious but safer. When a new treatment strategy is able to achieve better efficacy and safety, at an equal or lower cost, it becomes a “dominant” strategy. Few therapies in cardiovascular med...

The physician-scientist: a value proposition.

The American Society for Clinical Investigation has supported the career development of physician-scientists for the past 100 years. As the ASCI looks to its next 100 years, it must be a leading force, not only for advancing the research of physician-scientists, but also for stimulating public advocacy for biomedical research in this country.